Biotech Funding Tracker
12,069 funding rounds tracked across 5,657 companies since 1990
TOTAL TRACKED
$473.2B
LARGEST ROUND
$6.0B (Becton Dickinson)
TOTAL ROUNDS
12,069
COMPANIES
5,657
BIOTECH VC FUNDING
118 quarters · $473.2B total · Scroll to zoom
Data coverage improves for recent years. Pre-2010 data reflects major rounds only.
17,397 results
CompanyRoundAmountCountry
Fore BiotherapeuticsGrant$116KUnited States
Crossbow TherapeuticsVenture$77MUnited States
R1 TherapeuticsSeries A$78MUnited States
Prolium BioscienceVenture$50MUnited States
QL BiopharmSeries C$73MUnited States
Atrium TherapeuticsVenture$270MUnited States
BreezeBioVenture$60MUnited States
Slate MedicinesVenture$130MUnited States
Altesa BioSciencesSeries B$75MUnited States
Korsana BiosciencesVenture$175MUnited States
ILiAD BiotechnologiesVenture$115MUnited States
QuantX BiosciencesVenture$85MUnited States
Angitia BiopharmaceuticalsSeries D$130MUnited States
Third Arc BioSeries A$52MUnited States
Tenpoint TherapeuticsVenture$85MUnited States
Breakthru MedicinePIPE$60MUnited States
TRexBioPIPE$50MUnited States
Corxel PharmaceuticalsSeries D$287MUnited States
MendraSeries A$82MUnited States
Think BioscienceVenture$55MUnited States
ExcivaVenture$59MUnited States
CytotheryxVenture$60MUnited States
ProximaPIPE$80MUnited States
Vibrant TherapeuticsPIPE$61MUnited States
CytotheryxDebt$60MUnited States
Kinaset TherapeuticsVenture$103MUnited States
AirNexis TherapeuticsVenture$200MUnited States
MedipostIPO$140MUnited States
Parabilis MedicinesPIPE$305MUnited States
Alveus TherapeuticsVenture$160MUnited States
Diagonal TherapeuticsPIPE$125MUnited States
EpiBiologicsVenture$107MUnited States
Beacon TherapeuticsVenture$75MUnited States
Soley TherapeuticsPIPE$200MUnited States
Rakuten MedicalVenture$100MUnited States
Corsera HealthVenture$80MUnited States
Poplar TherapeuticsSeries A$50MUnited States
Syneron BioSeries A$100MUnited States
Syremis TherapeuticsSeries A$165MUnited States
Atavistik BioVenture$120MUnited States
Addition TherapeuticsGrant$100MUnited States
Aeovian PharmaceuticalsSeries B$55MUnited States
Ambros TherapeuticsSeries A$125MUnited States
Chai DiscoverySeries A$130MUnited States
Link Cell TherapiesSeed$60MUnited States
ProlynxSeries A$70MUnited States
D3 BioVenture$108MUnited States
BlossomHill TherapeuticsSeries B$84MUnited States
SanegeneBioSeries B$110MUnited States
MediGen AIFollow-on Offering$10MNetherlands
OTR TherapeuticsVenture$100MUnited States
SciNeuro PharmaceuticalsPIPE$53MUnited States
Triana BiomedicinesSeries B$120MUnited States
Protego BiopharmaSeries B$130MUnited States
TheraDiagPublic Offering$210MUnited States
Aspen NeuroscienceVenture$115MUnited States
ProfluentVenture$106MUnited States
Solve TherapeuticsVenture$120MUnited States
Artios PharmaSeries D$115MUnited States
Gate BioscienceVenture$65MUnited States
NanoMed SystemsSeries C$320MUnited States
MediVax AISeries C$45MUnited States
ImmunoTheraSeries C$135MUnited States
Braveheart BioVenture$185MUnited States
Azalea TherapeuticsSeed$82MUnited States
Neok BioVenture$75MUnited States
AAVantgarde BioSeries B$141MUnited States
Hemab TherapeuticsSeries C$157MUnited States
NeuroTech AISeries C$240MUnited States
Electra TherapeuticsSeries C$183MUnited States
Elevara MedicinesVenture$70MUnited States
TheraCell AISeries B$15MUnited Kingdom
AdcytherixPIPE$105MUnited States
PeptilogicsVenture$78MUnited States
TheraGenFollow-on Offering$120MFrance
TubulisVenture$361MUnited States
Pelage PharmaceuticalsSeries A$120MUnited States
Kailera TherapeuticsSeries B$600MUnited States
Kardigan TherapeuticsSeries B$254MUnited States
Lila SciencesSeries A$115MUnited States
Tr1XVenture$50MUnited States
ExcellergySeries A$70MUnited States
ImmunoLogicPIPE$380MUnited States
Expedition TherapeuticsSeries A$165MUnited States
BioHeal AIFollow-on Offering$75MJapan
Arthrosi TherapeuticsVenture$153MUnited States
Nilo TherapeuticsVenture$101MUnited States
Soufflé TherapeuticsVenture$200MUnited States
TORL BioTherapeuticsVenture$96MUnited States
BioHealPrivate Equity$170MUnited States
Cartography BiosciencesPIPE$67MUnited States
OncoC4PIPE$50MUnited States
ImmunoDxPrivate Equity$100MUnited States
Crystalys TherapeuticsVenture$205MUnited States
Star TherapeuticsPIPE$125MUnited States
TheraGen AIPublic Offering$50MFrance
Sparrow TherapeuticsSeries B$95MUnited States
GenomeAISeries B$190MUnited States
Avenzo TherapeuticsSeries A$60MUnited States
Ollin BiosciencesVenture$100MUnited States
Showing 100 of 17,397 rounds